Literature DB >> 7561217

Oligoclonal CD8 lymphocytes from persons with asymptomatic human immunodeficiency virus (HIV) type 1 infection inhibit HIV-1 replication.

J F Toso1, C H Chen, J R Mohr, L Piglia, C Oei, G Ferrari, M L Greenberg, K J Weinhold.   

Abstract

CD8 lymphocytes from asymptomatic human immunodeficiency virus (HIV) type 1-infected patients can suppress virus production from infected CD4 cells. Suppressive activity is separate and distinct from cytotoxic T lymphocyte (CTL) reactivities and is likely mediated by a soluble factor(s). The majority of HIV-1 suppression studies have been done in the context of bulk CD8 cell cultures. In this study, viral suppression was characterized by clonal populations of CD8 cells derived from HIV-1-infected patients. Most of the suppressive clones were devoid of detectable CTL reactivity against env-, gag-, pol-, and nef-expressing targets. Among the suppressive clones derived from an individual patient, a marked heterogeneity was evident with respect to phenotypic markers, cytokine production, and T cell receptor V beta expression. These results suggest that noncytolytic virus suppression is oligoclonal in nature. Clones provide tools for future studies aimed at understanding the mechanism of suppression and identifying the suppressive factor.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7561217     DOI: 10.1093/infdis/172.4.964

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Lysis of HIV-1-infected cells and inhibition of viral replication by universal receptor T cells.

Authors:  O O Yang; A C Tran; S A Kalams; R P Johnson; M R Roberts; B D Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 2.  The CD8+ T Cell Noncytotoxic Antiviral Responses.

Authors:  Maelig G Morvan; Fernando C Teque; Christopher P Locher; Jay A Levy
Journal:  Microbiol Mol Biol Rev       Date:  2021-05-12       Impact factor: 11.056

3.  Phenotypic and functional profile of HIV-inhibitory CD8 T cells elicited by natural infection and heterologous prime/boost vaccination.

Authors:  Stephanie A Freel; Laurie Lamoreaux; Pratip K Chattopadhyay; Kevin Saunders; David Zarkowsky; R Glenn Overman; Christina Ochsenbauer; Tara G Edmonds; John C Kappes; Coleen K Cunningham; Thomas N Denny; Kent J Weinhold; Guido Ferrari; Barton F Haynes; Richard A Koup; Barney S Graham; Mario Roederer; Georgia D Tomaras
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

Review 4.  Immunity to retroviral infection: the Friend virus model.

Authors:  K J Hasenkrug; B Chesebro
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

5.  Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.

Authors:  G Ferrari; W Humphrey; M J McElrath; J L Excler; A M Duliege; M L Clements; L C Corey; D P Bolognesi; K J Weinhold
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

6.  Epigenetic regulation of CD8(+) T-lymphocyte mediated suppression of HIV-1 replication.

Authors:  Kevin O Saunders; Stephanie A Freel; R Glenn Overman; Coleen K Cunningham; Georgia D Tomaras
Journal:  Virology       Date:  2010-07-01       Impact factor: 3.616

7.  Noninfectious papilloma virus-like particles inhibit HIV-1 replication: implications for immune control of HIV-1 infection by IL-27.

Authors:  J Mohamad Fakruddin; Richard A Lempicki; Robert J Gorelick; Jun Yang; Joseph W Adelsberger; Alfonso J Garcia-Pineres; Ligia A Pinto; H Clifford Lane; Tomozumi Imamichi
Journal:  Blood       Date:  2006-10-26       Impact factor: 22.113

8.  Suppression of human immunodeficiency virus type 1 replication by CD8+ cells: evidence for HLA class I-restricted triggering of cytolytic and noncytolytic mechanisms.

Authors:  O O Yang; S A Kalams; A Trocha; H Cao; A Luster; R P Johnson; B D Walker
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

9.  Natural suppression of human immunodeficiency virus type 1 replication is mediated by transitional memory CD8+ T cells.

Authors:  M Scott Killian; Carl Johnson; Fernando Teque; Sue Fujimura; Jay A Levy
Journal:  J Virol       Date:  2010-12-08       Impact factor: 5.103

10.  HLA compatibility requirements for CD8(+)-T-cell-mediated suppression of human immunodeficiency virus replication.

Authors:  C E Mackewicz; M R Garovoy; J A Levy
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.